Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Virbac S.A. | 1 | 0 | 0 | 0 | €348.50 | - | - |
| Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.75 | - | - |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.70 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €44.40 | - | - |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.23 | - | - |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.88 | - | - |
| Enlivex Therapeutics Ltd. | 1 | 0 | 1 | 0 | €1.49 | - | - |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.42 | - | - |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.37 | - | - |
| Adaptimmune Therapeutics PLC ADR | 2 | 0 | 2 | 0 | €1.10 | €1.70 | 54.545% |
| X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €1.07 | €2.78 | 158.705% |
| ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.87 | €2.81 | 50.283% |
| Aclaris Therapeutics Inc | 1 | 0 | 1 | 0 | €1.26 | €3.00 | 138.284% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.66 | €3.00 | 80.723% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.28 | €3.60 | 181.840% |
| Compugen Ltd. | 3 | 2 | 1 | 0 | €2.01 | €3.67 | 82.813% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.75 | €4.39 | 150.645% |
| Heron Therapeutics Inc. | 9 | 1 | 4 | 0 | €2.42 | €4.57 | 89.000% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.62 | €4.63 | 27.785% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.72 | €4.63 | 541.177% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.52 | €5.00 | 10.619% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.61 | €5.34 | 231.017% |